During this Conference, Valentín Ceña presented line of action 5 at the University of Castilla-La Mancha: “Pharmacological characterization of nanoparticles” in collaboration with the Singular Center for Research in Molecular Medicine and Chronic Diseases (USC) and CICbioGUNE focused on treatment of glioblastoma with nanoparticles.
YOUNG RESEARCHERS FROM CASTILLA-LA MANCHA PRESENT THEIR RESULTS ON THERAPEUTIC NANOPARTICLES IN TOLEDO.
11 de September de 2024
On September 6, the first scientific meeting of the Institute of Nanoscience, Nanotechnology and Molecular Materials (INAMOL) belonging to the University of Castilla-La Mancha was held, attended by more than 50 scientists. Within this meeting,
